Contract facts
FederalPER SECTION 711 NDAA 2019 THE U.S. ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY (USAMRAA), U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND (USAMRDC) TRANSFERRED TO THE DEFENSE HEALTH AGENCY (DHA) FROM THE U.S. ARMY EFFECTIVE 01 OCTOBER 2022 is a federal award for W4pz Usa Med Rsch Acquis Act held by Leidos, Inc. Estimated value $2M ($-18,627.73 obligated). Current period of performance ends Aug 30, 2019. Place of performance: FREDERICK MD. Related solicitation W81XWH17R0036.
PER SECTION 711 NDAA 2019 THE U.S. ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY (USAMRAA), U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND (USAMRDC) TRANSFERRED TO THE DEFENSE HEALTH AGENCY (DHA) FROM THE U.S. ARMY EFFECTIVE 01 OCTOBER 2022
Recompete timing
PublicCurrent PoP ended Aug 30, 2019 (2548 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordLeidos, Inc — $3.2B obligated across 1,081 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81XWH18F0367?
W81XWH18F0367 (Usamraa usamrdc and) is a W4pz Usa Med Rsch Acquis Act award with a potential value of $2M, currently held by Leidos, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W81XWH-18-F-0367?
W81XWH-18-F-0367 is the dashed form of PIID W81XWH18F0367 (Usamraa usamrdc and), held by Leidos, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W81XWH18F0367?
W4pz Usa Med Rsch Acquis Act awarded W81XWH18F0367 to Leidos, Inc (potential $2M).
Who is the incumbent on W81XWH18F0367?
Leidos, Inc is the incumbent with $3.2B across 1081 related awards in SCOUT’s public footprint. The current period of performance ends Aug 30, 2019.
When does Leidos, Inc’s W81XWH18F0367 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 30, 2019. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.